ZEVTERA 500 MG / VIAL — DIN 02446685
ZEVTERA · AVIR PHARMA INC. · wholesale supply in Canada
Health Canada status: MARKETED
What is ZEVTERA?
ZEVTERA 500 MG / VIAL contains ZEVTERA. It is listed in the Health Canada Drug Product Database under DIN 02446685, held by AVIR PHARMA INC.. Health Canada currently lists it as marketed, status dated 20-Mar-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is ZEVTERA used for?
Treatment of hospital-acquired pneumonia (HAP), excluding ventilator-associated pneumonia (VAP), and community-acquired pneumonia (CAP) caused by susceptible strains of designated microorganisms in patients 18 years of age and older.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 500 MG / VIAL |
|---|---|
| Pack configuration (monograph) | 20 mL clear type I glass vials fitted with a grey butyl closure and an aluminum seal with a blue plastic flip-off cap. A carton contains 10 vials. |
| Storage | The reconstituted solution can be stored at room temperature for up to 1 hour, or in a refrigerator for up to 24 hours. |
| Shipping class | Cold chain — validated shipper with temperature monitoring |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
Cold chain. This product is stored refrigerated. Nexara ships it on a validated cold chain with temperature monitoring; a delivery address that cannot receive and store it at 2–8 °C on arrival must be flagged before the order is placed.
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02446685 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2446685 |
| Brand name | ZEVTERA |
| Generic / active ingredient | ZEVTERA |
| Market authorization holder | AVIR PHARMA INC. |
| Health Canada schedule | PRESCRIPTION |
| Current status | MARKETED |
| Status date | 20-Mar-2018 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Recommended dose is 500 mg administered as a 2-hour intravenous infusion every 8 hours. Usual treatment duration is 4–14 days for CAP, and 7–14 days for HAP.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity to ceftobiprole medocaril, any ingredient in the formulation, cephalosporin class of antibacterials, or immediate and severe hypersensitivity to any other beta-lactam antibacterial agent.
Warnings and precautions
Serious and occasionally fatal hypersensitivity (anaphylactic) and severe cutaneous adverse reactions (SCAR) have been reported. Prolonged use may result in overgrowth of non-susceptible organisms.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.